IM-UNITI: Three-year efficacy, safety, and immunogenicity of ustekinumab treatment of Crohn's disease

Stephen B. Hanauer*, William J. Sandborn, Brian G. Feagan, Christopher Gasink, Douglas Jacobstein, Bin Zou, Jewel Johanns, Omoniyi J. Adedokun, Bruce E. Sands, Paul Rutgeerts, Willem J.S. De Villiers, Jean Frédéric Colombel, Subrata Ghosh

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

188 Scopus citations

Fingerprint

Dive into the research topics of 'IM-UNITI: Three-year efficacy, safety, and immunogenicity of ustekinumab treatment of Crohn's disease'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science